Laetrile treatment for cancer

Cochrane Database of Systematic Reviews

Volumn 2011, Issue 11, 2011, Pages

  Milazzo, Stefania ^a   Ernst, Edzard ^b   Lejeune, Stephane ^c   Boehm, Katja ^a   Horneber, Markus ^a  

^a KLINIKUM NÜRNBERG   (Germany)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c EORTC DATA CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMYGDALIN; ANTINEOPLASTIC AGENT;

HUMAN; NEOPLASM; REVIEW;

AMYGDALIN; ANTINEOPLASTIC AGENTS, PHYTOGENIC; HUMANS; NEOPLASMS;

EID: 84860808288     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD005476.pub3     Document Type: Review

References (49)

1. Ames MM, Moyer TP, Kovach JS, Moertel CG, Rubin J. Pharmacology of amygdalin (laetrile) in cancer patients. Cancer Chemotherapy Pharmacology 1981;6(1):51-7.
2. Cancer Commission of the California Medical Association. Treatment of cancer with laetrile; a report by the Cancer Commission of the California Medical Association. California Medicine 1953;78(4):320-6.
3. CPW-Rahlstedt Company. Summary of clinical efficacy of CDA therapy II. Internal data of the company.
4. Guidetti H. Preliminary reports on several cases of cancer treated with a cyanogenetic glycoside [Observations preliminaries sur quelques cas de cancer traits par un glycuronosyde cyanogenetique]. Acta 1955;XI (2):156-8.
5. Kochi M, Takeuchi S, Mizutani T, Mochizuki K, Matsumoto Y, Saito Y. Antitumor activity of benzaldehyde. Cancer Treat Reports 1980;64(1):21-3.
6. Kochi M, Isono N, Niwayama M, Shirakabe K. Antitumor activity of a benzaldehyde derivative. Cancer Treat Reports 1985;69(5):533-7.
7. Moertel CG, Ames MM, Kovach JS, Moyer TP, Rubin JR, Tinker JH. A pharmacologic and toxicological study of amygdalin. The Journal of the American Medical Association 1981;245(6):591-4.
8. Moertel CG, Fleming TR, Rubin J, Kvols LK, Sarna G, Koch R, et al.A clinical trial of amygdalin (Laetrile) in the treatment of human cancer. New England Journal of Medicine 1982;306(4):201-6.
9. Morrone JA. Chemotherapy of inoperable cancer: preliminary report of 10 cases treated with laetrile. Experimental Medicine Surgery 1962;20:299-308.
10. Navarro MD. The mechanism of action and therapeutic effects of laetrile in cancer. Journal Philippine Medical Association 1957;33(8):620-7.
11. Navarro MD. Five years experience with laetrile therapy in advanced cancer. Acta Unio Internationalis Contra Cancrum 1959;15:209-21.
12. Navarro MD. Laetrile therapy in cancer. Acta Unio Internationalis Contra Cancrum 1964;20:392-4.
13. Sakamoto S, Yoshino H, Shirahata Y, Shimodairo K, Okamoto R. Pharmacotherapeutic effects of kuei-chih-fu-ling-wan (keishi-bukuryo-gan) on human uterine myomas. Amermican Journal of Chinese Medicine 1992;20(3-4):313-7.
14. Suehiro T, Matsumata T, Shikada Y, Sugimachi K. The effect of the herbal medicines dai-kenchu-to and keishi-bukuryo-gan on bowel movement after colorectal surgery. Hepatogastroenterology 2005 Jan-Feb;52(61):97-100.
15. Tasca M. Clinical observations on the therapeutic effects of a cyanogenetic glycuronoside in cases of human malignant neoplasms. Gazzetta Medica Italiana 1959;118(4):153-9.
16. Barrett S. Laetrile Spammers Facing $631, 585 Penalty. www.quackwatch.org/04ConsumerEducation/News/apricotseeds.html (accessed on 3rd May 2011).
17. Bromley J, Hughes BG, Leong DC, Buckley NA. Life-threatening interaction between complementary medicines: cyanide toxicity following ingestion of amygdalin and vitamin C. Annals of Pharmacotherapy 2005;39(9):1566-9.
18. Calabrese EJ. Possible side effects from treatment with laetrile. Medical Hypotheses 1979;5(9):1045-9.
19. Chan TY. A probable case of amygdalin-induced peripheral neuropathy in a vegetarian with vitamin B12 deficiency. Therapeutic Drug monitoring 2006;28(1):140-1.
20. Chang HK, Shin MS, Yang HY, Lee JW, Kim YS, Lee MH, et al.Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells. Biological & Pharmaceutical Bulletin 2006 Aug;29(8):1597-602.
21. Curran WJ. Law-medicine notes. Laetrile for the terminally ill: Supreme Court stops the nonsense. The New England Journal of Medicine 1980;302 (11):619-21.
22. Davignon JP, Trissel LA, Kleinman LM. Pharmaceutical assessment of amygdalin (Laetrile) products. Cancer Treatment Reports 1978;62(1):99-104.
23. Dorr RT, Paxinos J. The current status of laetrile. Annals of Internal Medicine 1978;89 (3):389-97.
24. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
25. Egger M. Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd Edition. London: BMJ Publishing Group, 2001.
26. Ellison NM, Byar DP, Newell GR. Special report on laetrile: NCI (National Cancer Institute) laetrile review. The New England Journal of Medicine September 1978;299:549-52.
27. Fenselau C, Pallante S, Batzinger RP, Benson WR, Barron RP, Sheinin EB, et al.Mandelonitrile beta-glucuronide: synthesis and characterization. Science 1977;198(4317):625-7.
28. Fukuda T, Ito H, Mukainaka T, Tokuda H, Nishino H, Yoshida T. Anti-tumor promoting effect of glycosides from Prunus persica seeds. Biological and Pharmaceutical Bulletin 2003;26(2):271-3.
29. Gibbs M. Networking topics for palliative care. The Pharmaceutical Journal 2004;273(7320):539.
30. Higgins JPT. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
31. Hu S, Yuan D, Diao GF, Bi KS, Kano Y. Studies on evaluation of Semen Armeniacae amarum. Zhongguo Zhong Yao Za Zhi (China Journal of Materia Medica) 2002;27 (10):736-9.
32. Hwang EY, Lee JH, Lee YM, Hong SP. Reverse-phase HPLC separation of D-amygdalin and neoamygdalin and optimum conditions for inhibition of racemization of amygdalin. Chemical and Pharmaceutical Bulletin (Tokyo) 2002;50(10):1373-5.
33. Kwon HY, Hong SP, Hahn DH, Kim JH. Apoptosis induction of Persicae Semen extract in human promyelocytic leukemia (HL-60) cells. Archives of Pharmacal Research 2003;26(2):157-61.
34. Lerner IJ. Laetrile: a lesson in cancer quackery. CA: A Cancer Journal for Clinicians 1981;31(2):91-5.
35. Meijer E. Sale over the Internet of substances for human consumption which are regarded as harmful in America. Official Journal of the European Communities (2001/C 151 E/071). http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2001:151E:0058:0059:EN:PDF (Last accessed 3rd May 2011) 2001.
36. Miller KW, Anderson JL, Stoewsand GS. Amygdalin metabolism and effect on reproduction of rats fed apricot (Prunus armeniaca) kernels. Journal of Toxicology and Environmental Health 1981;7(3-4):457-68.
37. National Cancer Institute. Laetrile/Amygdalin (PDQ®). http://www.nci.nih.gov/cancertopics/pdq/cam/laetrile/healthprofessional/allpages (accessed on 16th June 2011).
38. Park HJ, Yoon SH, Han LS, Zheng LT, Jung KH, Uhm YK, et al.Amygdalin inhibits genes related to cell cycle in SNU-C4 human colon cancer cells. World Journal of Gastroenterology 2005;11(33):5156-61.
39. Parmar MK. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34.
40. Relman, A . Closing the books on Laetrile. New England Journal of Medicine 1982;306(4):236.
41. Schmidt K, Ernst E. Assessing websites on complementary and alternative medicine for cancer. Annals of Oncology 2004;15:733-42.
42. Seers H, Cooke H, CAM-Cancer Consortium. CAM Summary Laetrile. http://www.cam-cancer.org/CAM-Summaries/Biologically-Based-Practices/Laetrile 2009.
43. Shaffer David. Not available. The associated Press July 16, 1979.
44. Shim SM, Kwon H. Metabolites of amygdalin under simulated human digestive fluids. Internationl Journal of Food Sciences and Nutrition 2010;61(8):770-9.
45. Takafumi I, Yutaka M, Keiichi Y, Noboru K, Tadato T. Quantitative determination of amygdalin epimers by cyclodextrin-modified micellar electrokinetic chromatography. Journal of Chromatography 2001;923(1-2):249-54.
46. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al.New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. Journal of the National Cancer Institute 2000;92(3):205-16.
47. Vetter J. Plant cyanogenic glycosides. Toxicon 2000;38(1):11-36.
48. Milazzo S, Ernst E, Lejeune S, Boehm K. Laetrile treatment for cancer. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD005476.pub2]
49. Milazzo S, Lejeune S, Ernst E. Laetrile for cancer: a systematic review of the clinical evidence. Supportive Care in Cancer 2007 June;15(6):583-95.